ArticleCureus2024
Immune Thrombocytopenic Purpura Secondary to Cytomegalovirus (CMV) Infection: A Clinical Case.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immune thrombocytopenic purpura (ITP) is an autoimmune condition characterized by a reduced platelet count due to enhanced peripheral destruction and impaired platelet production. While thrombocytopenia is a well-documented complication of various viral infections, cytomegalovirus (CMV), a member of the Herpesviridae family, is primarily associated with infections in immunocompromised patients and is rarely implicated in causing severe thrombocytopenia in immunocompetent patients. This article aims to highlight the importance of considering CMV as a significant etiological factor in ITP, particularly in cases of asymptomatic thrombocytopenia. A 34-year-old male presented to the emergency department with a one-week history of progressively worsening erythematous macules on the lower extremities, extending proximally, accompanied by spontaneous ecchymoses, ulcerative and hemorrhagic aphthous lesions in the oral cavity and recurrent episodes of epistaxis. Physical examination revealed petechiae on the ear pavilions, face, trunk, back, upper limbs, abdomen and lower limbs. Intraorally, multiple ulcers and violaceous lesions were observed on the buccal mucosa and tonsillar regions. Additionally, the patient exhibited a localized area of ecchymosis with a central crusted lesion on the right lower leg. Serologic testing for CMV was positive and targeted antiviral therapy was initiated. CMV infection can lead to severe thrombocytopenia in otherwise healthy adults, despite diagnostic challenges. These challenges arise due to the low incidence of severe CMV disease, its diverse clinical manifestations, and its ability to mimic symptoms of other common illnesses. In cases of ITP that resist standard treatments, antiviral therapy may be necessary and should be promptly initiated if CMV infection is confirmed. CMV infection should be included in the differential diagnosis for severe thrombocytopenia in healthy adults, especially following a recent viral infection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.